Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

CSIR divulges tricyclic antineoplastics

Sep. 2, 2015

Karus discloses PI3K inhibitors

Sep. 2, 2015

Takeda discloses GPR6 modulators

Sep. 2, 2015

Bristol-Myers Squibb reports HIV integrase inhibitors

Sep. 2, 2015

Incyte discloses LSD1 inhibitors

Sep. 1, 2015

Lundbeck divulges BACE1 inhibitors

Sep. 1, 2015

Bristol-Myers Squibb patents HIV integrase inhibitors

Sep. 1, 2015

Takeda presents OX1 receptor antagonists

Sep. 1, 2015

Bayer discloses BRD4 inhibitors

Sep. 1, 2015

Bayer and DKFZ present inhibitors of mutated IDH1

Aug. 31, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...